Mitsui E&S Holdings Co., Ltd.
Mitsui E&S Holdings Co., Ltd. (MIESY) Financial Performance & Income Statement Overview
Review Mitsui E&S Holdings Co., Ltd. (MIESY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Mitsui E&S Holdings Co., Ltd. (MIESY) Income Statement & Financial Overview
Review Mitsui E&S Holdings Co., Ltd. MIESY income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $96.37B | $73.70B | $74.98B | $70.06B |
Cost of Revenue | $79.14B | $62.46B | $63.17B | $58.77B |
Gross Profit | $17.22B | $11.25B | $11.80B | $11.29B |
Gross Profit Ratio | $0.18 | $0.15 | $0.16 | $0.16 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $7.85B | $6.71B | $6.89B | $6.99B |
Operating Expenses | $7.85B | $6.71B | $6.89B | $7.00B |
Total Costs & Expenses | $86.99B | $69.17B | $70.06B | $65.76B |
Interest Income | $127.00M | $60.00M | $122.00M | $80.00M |
Interest Expense | $499.00M | $507.00M | $654.00M | $899.00M |
Depreciation & Amortization | $2.27B | $2.15B | $2.08B | $2.12B |
EBITDA | $4.09B | $6.69B | $7.00B | $6.42B |
EBITDA Ratio | $0.04 | $0.09 | $0.09 | $0.09 |
Operating Income | $9.38B | $4.54B | $4.92B | $4.30B |
Operating Income Ratio | $0.10 | $0.06 | $0.07 | $0.06 |
Other Income/Expenses (Net) | -$8.73B | -$1.13B | -$2.08B | $28.52B |
Income Before Tax | $645.00M | $3.41B | $2.84B | $32.82B |
Income Before Tax Ratio | $0.007 | $0.05 | $0.04 | $0.47 |
Income Tax Expense | -$3.34B | $353.00M | -$462.00M | $4.003B |
Net Income | $3.88B | $2.91B | $3.49B | $28.79B |
Net Income Ratio | $0.04 | $0.04 | $0.05 | $0.41 |
EPS | $36.54 | $32.26 | $30.87 | $285.41 |
Diluted EPS | $36.54 | $30.76 | $32.69 | $283.56 |
Weighted Avg Shares Outstanding | $106.20M | $96.19M | $106.83M | $100.88M |
Weighted Avg Shares Outstanding (Diluted) | $100.89M | $100.89M | $100.89M | $101.54M |
Over the past four quarters, Mitsui E&S Holdings Co., Ltd. demonstrated steady revenue growth, increasing from $70.06B in Q1 2024 to $96.37B in Q4 2024. Operating income reached $9.38B in Q4 2024, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $4.09B, reflecting operational efficiency. Net income rose to $3.88B, with EPS at $36.54. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan